Audited Supplier
HRXY-33I
Abdominal
Disposable
CE
2 Years
Huaren
Carton
Single/double pipe
China
Product Description
Drug name :Disposable Abdominal Suction and Irrigation Set
Description:
In various invasive surgeries, especially laparoscopic surgeries, bleeding occurs at the surgical site, and there may also be stasis of blood and residual fluid in the body, which needs to be flushed and aspirated.
Advantages:
(1)Pressure relief design,Don't worry about sucking and pulling damage to the organs.
(2)Push-button for smooth pouring and suction.
(3)360 ° linear distribution of suction holes.
(4)The integrated flushing and suction gun handle eliminates the need to worry about cumbersome switching between flushing and suctioning.
Specification:
| Specification | characteristic |
| HRXY-33 I | The stainless steel tube is a single tube and can pass through the 5ML puncture device |
| HRXY-33 II | The stainless steel tube is a double tube and cannot pass through the 5ML puncture device, so the pressure relief effect is more obvious. |
| HRXY-43 I | The stainless steel tube is a single tube or a long tube, which can pass the 5ML puncture device |
| HRXY-43 II | The stainless steel tube is a double tube and a long tube, which cannot pass through the 5ML puncture device, and the pressure relief effect is more obvious. |
Founded in May 1998, Huaren Pharmaceutical is a modern pharmaceutical and health industry group integrating R&D, production and sales, focusing on medicine, health, medical equipment and medical services.
In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.
After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".
In August 2010, the company was successfully listed on the Shenzhen Stock Exchange, the stock abbreviation is "Huaren Pharmaceutical", stock code "300110". In July 2019, the company underwent a change of shareholding, and the management committee of Xi'an Qujiang New Area became the actual controller of the company.
After more than 20 years of development, the company's business focuses on nephrology, respiratory, fine hemp and large-volume preparations and other fields, and has successively built five production bases in Qingdao, Rizhao, Xiaogan, Pubei and Hefei, with a total production capacity of 950 million bags (bottles), and all production lines have passed the new GMP certification. The company's main products include small-volume injections, peritoneal dialysate, therapeutic infusions, basic infusions, medical devices, tablets, capsules, powders, granules, supporting drug packaging, health products and APIs, etc., with a total of 98 varieties and 212 specifications of existing drugs, realizing the integrated development of "raw materials + preparations + pharmaceutical packaging materials".
Pharmaceutical packaging materials,Rubber stoppers and APIs are self-produced and self-sold, the price is lower and the quality is more guaranteed.
